Detalhe da pesquisa
1.
Assessment of the Sun Nuclear ArcCHECK to detect errors in 6MV FFF VMAT delivery of brain SABR using ROC analysis.
J Appl Clin Med Phys
; 22(6): 35-44, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021691
2.
Impact of and interplay between proton arc therapy and range uncertainties in proton therapy for head-and-neck cancer.
Phys Med Biol
; 69(5)2024 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324904
3.
Validation of an MR-based multimodal method for molecular composition and proton stopping power ratio determination using ex vivo animal tissues and tissue-mimicking phantoms.
Phys Med Biol
; 68(17)2023 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463589
4.
Range uncertainty reductions in proton therapy may lead to the feasibility of novel beam arrangements which improve organ-at-risk sparing.
Med Phys
; 49(7): 4693-4704, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362163
5.
Validation of prompt gamma-ray spectroscopy for proton range verification in tissue-mimicking and porcine samples.
Phys Med Biol
; 67(20)2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162404
6.
Proton range uncertainty reduction benefits for skull base tumors in terms of normal tissue complication probability (NTCP) and healthy tissue doses.
Med Phys
; 48(9): 5356-5366, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260085
7.
3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
EJNMMI Res
; 9(1): 76, 2019 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31414241
8.
Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach.
EJNMMI Res
; 8(1): 76, 2018 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076556